Shin, Y., Moon, J. H., Chin, H. J., Ferrannini, E., & Lim, S. (2020). Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea. Endocrinol Metab (Seoul).

Shin, Yujin, Ji Hye Moon, Ho Jun Chin, Ele Ferrannini, und Soo Lim. "Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on Versus Conventional Dose-Increasing Strategy in Patients With Type 2 Diabetes Inadequately Controlled By Metformin and Sulfonylurea." Endocrinol Metab (Seoul) 2020.

Shin, Yujin, et al. "Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on Versus Conventional Dose-Increasing Strategy in Patients With Type 2 Diabetes Inadequately Controlled By Metformin and Sulfonylurea." Endocrinol Metab (Seoul) 2020.